help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El Meskini, R.
Right arrow Articles by Ouafik, L'H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El Meskini, R.
Right arrow Articles by Ouafik, L'H.
Endocrinology Vol. 138, No. 12 5256-5265
Copyright © 1997 by The Endocrine Society

ARTICLES

Estrogen Regulation of Peptidylglycine {alpha}-Amidating Monooxygenase Messenger Ribonucleic Acid Levels by a Nuclear Posttranscriptional Event1

Rajaâ El Meskini, Françoise Boudouresque and L’Houcine Ouafik

INSERM U297, Institut Federatif de Recherche Jean Roche, Faculté de Médecine Nord, 13916 Marseille Cedex 20, France

Address all correspondence and requests for reprints to: Dr. L’Houcine Ouafik, INSERM U297, Institut Federatif de Recherche Jean Roche, Faculté de Médecine Nord, Boulevard Pierre Dramard, 13916 Marseille Cedex 20, France. E-mail: ouafik.h{at}jean-roche.univ-mrs.fr

Peptidylglycine {alpha}-amidating monooxygenase (PAM; EC 1.14.17.3) is a bifunctional protein containing two enzymes that act sequentially to catalyze the conversion of glycine-extended peptides into COOH-terminal amidated peptides. We have previously shown that PAM messenger RNA (mRNA) levels in the anterior pituitary of intact cycling adult female rats showed changes inversely related to the physiological variations of plasma estrogen levels during the estrous cycle. Chronic treatment of ovariectomized (OVX) rats with 17ß-estradiol was accompanied by a 4.5 ± 0.5-fold decrease in total PAM mRNA and a 2-fold decrease in PAM activity in the anterior pituitary gland.

To investigate the cellular site at which 17ß-estradiol acts to affect the PAM mRNA, we made parallel measurements of the relative levels of PAM mRNA and nuclear precursor RNA and the relative rate of gene transcription after treatments designed to alter the estrogen status. The transcription rate experiments indicated that these 17ß-estradiol effects were not due to reduced PAM gene activity, suggesting that a posttranscriptional mechanism was involved. The most common mechanism of posttranscriptional regulation affects cytoplasmic mRNA stability. Primary rat pituitary cell cultures from OVX and OVX-17ß-estradiol-treated rats in the presence of actinomycin D showed that 17ß-estradiol treatment decreased the half-life of PAM mRNA from 15–16 h to 8–9 h. There was no effect of 17ß-estradiol on PAM mRNA poly(A) tail length or site of polyadenylation. However, in this study the down-regulation of PAM was identified as a nuclear event. Analysis of nuclear RNA with probes specific for PAM intron sequences shows that decreased PAM expression after 17ß-estradiol treatment was largely due to intranuclear destabilization of the primary transcript. The levels of nuclear precursor RNA were decreased roughly 5- to 6-fold in OVX+17ß-estradiol compared with OVX rats. The decrease in PAM mRNA is blocked by cycloheximide, indicating that its requires new protein synthesis. Mechanisms that would generate such an effect include altered stability of unprocessed message in the nucleus. The proportional changes observed in the nuclear precursor and mRNA levels suggest that the site of control is at the level of stability of the nuclear precursor RNA for PAM mRNA.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
F. Brenet, N. Dussault, J. Borch, G. Ferracci, C. Delfino, P. Roepstorff, R. Miquelis, and L. Ouafik
Mammalian Peptidylglycine {alpha}-Amidating Monooxygenase mRNA Expression Can Be Modulated by the La Autoantigen
Mol. Cell. Biol., September 1, 2005; 25(17): 7505 - 7521.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
N. H. Ing
Steroid Hormones Regulate Gene Expression Posttranscriptionally by Altering the Stabilities of Messenger RNAs
Biol Reprod, June 1, 2005; 72(6): 1290 - 1296.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
X. Zheng, K. Kelley, H. Elnakat, W. Yan, T. Dorn, and M. Ratnam
mRNA Instability in the Nucleus Due to a Novel Open Reading Frame Element Is a Major Determinant of the Narrow Tissue Specificity of Folate Receptor {alpha}
Mol. Cell. Biol., March 15, 2003; 23(6): 2202 - 2212.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. L. Hodge, A. Martinez, J. G. Julias, L. S. Taylor, and H. A. Young
Regulation of Nuclear Gamma Interferon Gene Expression by Interleukin 12 (IL-12) and IL-2 Represents a Novel Form of Posttranscriptional Control
Mol. Cell. Biol., March 15, 2002; 22(6): 1742 - 1753.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Y. Seong, S. Park, and K. Kim
Enhanced Splicing of the First Intron from the Gonadotropin-Releasing Hormone (GnRH) Primary Transcript Is a Prerequisite for Mature GnRH Messenger RNA: Presence of GnRH Neuron-Specific Splicing Factors
Mol. Endocrinol., November 1, 1999; 13(11): 1882 - 1895.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. R. Provost and Y. Tremblay
Length Increase of the Human alpha -Globin 3'-Untranslated Region Disrupts Stability of the Pre-mRNA but Not That of the Mature mRNA
J. Biol. Chem., September 22, 2000; 275(39): 30248 - 30255.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society